SARAH MIKA: Open Payments
NPI 1497072466 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$255 in 12 payments from 8 companies in 2025. Trend: 2023 $737 · 2024 $1,192 · 2025 $255
Food & beverage: $255
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $54 |
| Lundbeck LLC | 2 | $50 |
| Novo Nordisk Inc | 2 | $36 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $33 |
| Daiichi Sankyo Inc. | 1 | $26 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| Organon LLC | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
Products named: REXULTI, Wegovy, INJECTAFER, RECOMBIVAX HB, NEXPLANON, MYFEMBREE.
Industry payments across MI — which companies pay providers there.
